nature.com search

Loading Filters

Showing 1–23 of 23 results

Loading Filters

Research | 15 December 2020
Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-κB
- Manikandan Periyasamy
- , Anup K. Singh
- , Carolina Gemma
- , Raed Farzan
- , Rebecca C. Allsopp
- , Jacqueline A. Shaw
- , Sara Charmsaz
- , Leonie S. Young
- , Paula Cunnea
- , R. Charles Coombes
- , Balázs Győrffy
- , Lakjaya Buluwela
- & Simak Ali
Oncogene , 1–14

Rights & permissionsfor article Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-κB . Opens in a new window.
Research | 1 September 2020 | Open
Currently favored sampling practices for tumor sequencing can produce optimal results in the clinical setting
Scientific Reports 10 , 1–8

Rights & permissionsfor article Currently favored sampling practices for tumor sequencing can produce optimal results in the clinical setting . Opens in a new window.
Research | 21 July 2020
BRD4 regulates key transcription factors that drive epithelial–mesenchymal transition in castration-resistant prostate cancer
Prostate Cancer and Prostatic Diseases , 1–10

Rights & permissionsfor article BRD4 regulates key transcription factors that drive epithelial–mesenchymal transition in castration-resistant prostate cancer . Opens in a new window.
Amendments and Corrections | 26 July 2018 | Open
Author Correction: Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Scientific Reports 8 , 1–1

Rights & permissionsfor article Author Correction: Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets . Opens in a new window.
Amendments and Corrections | 19 August 2019 | Open
Author Correction: SREBP1 drives keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer
- Ylenia Perone
- , Aaron J. Farrugia
- , Alba Rodríguez-Meira
- , Balázs Győrffy
- , Charlotte Ion
- , Andrea Uggetti
- , Antonios Chronopoulos
- , Pasquale Marrazzo
- , Monica Faronato
- , Sami Shousha
- , Claire Davies
- , Jennifer H. Steel
- , Naina Patel
- , Armando del Rio Hernandez
- , Charles Coombes
- , Giancarlo Pruneri
- , Adrian Lim
- , Fernando Calvo
- & Luca Magnani
Nature Communications 10 , 1–1

Rights & permissionsfor article Author Correction: SREBP1 drives keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer . Opens in a new window.
Amendments and Corrections | 6 August 2019 | Open
Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
- Van T. M. Nguyen
- , Iros Barozzi
- , Monica Faronato
- , Ylenia Lombardo
- , Jennifer H. Steel
- , Naina Patel
- , Philippa Darbre
- , Leandro Castellano
- , Balázs Győrffy
- , Laura Woodley
- , Alba Rodriguez-Meira
- , Darren K. Patten
- , Valentina Vircillo
- , Manikandan Periyasamy
- , Simak Ali
- , Gianmaria Frige
- , Saverio Minucci
- , R. Charles Coombes
- & Luca Magnani
Nature Communications 10 , 1–1

Rights & permissionsfor article Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion . Opens in a new window.
Research | 5 April 2019 | Open
Mapping Bromodomains in breast cancer and association with clinical outcome
Scientific Reports 9 , 1–10

Rights & permissionsfor article Mapping Bromodomains in breast cancer and association with clinical outcome . Opens in a new window.
Research | 23 January 2019 | Open
Independent validation of induced overexpression efficiency across 242 experiments shows a success rate of 39%
Scientific Reports 9 , 1–6

Rights & permissionsfor article Independent validation of induced overexpression efficiency across 242 experiments shows a success rate of 39% . Opens in a new window.
Research | 11 June 2020
Ribosomal protein S11 influences glioma response to TOP2 poisons
- Chidiebere U. Awah
- , Li Chen
- , Mukesh Bansal
- , Aayushi Mahajan
- , Jan Winter
- , Meeki Lad
- , Louisa Warnke
- , Edgar Gonzalez-Buendia
- , Cheol Park
- , Daniel Zhang
- , Eric Feldstein
- , Dou Yu
- , Markella Zannikou
- , Irina V. Balyasnikova
- , Regina Martuscello
- , Silvana Konerman
- , Balázs Győrffy
- , Kirsten B. Burdett
- , Denise M. Scholtens
- , Roger Stupp
- , Atique Ahmed
- , Patrick Hsu
- & Adam M. Sonabend
Oncogene 39 , 5068–5081

Rights & permissionsfor article Ribosomal protein S11 influences glioma response to TOP2 poisons . Opens in a new window.
Research | 15 June 2018 | Open
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Scientific Reports 8 , 1–9

Rights & permissionsfor article Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets . Opens in a new window.
Research | 21 March 2018 | Open
An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes
- Balázs Győrffy
- , Lőrinc Pongor
- , Giulia Bottai
- , Xiaotong Li
- , Jan Budczies
- , András Szabó
- , Christos Hatzis
- , Lajos Pusztai
- & Libero Santarpia
British Journal of Cancer 118 , 1107–1114

Rights & permissionsfor article An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes . Opens in a new window.
25 July 2005
Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival
- Balázs Györffy
- , Violeta Serra
- , Karsten Jürchott
- , Rula Abdul-Ghani
- , Mitch Garber
- , Ulrike Stein
- , Iver Petersen
- , Hermann Lage
- , Manfred Dietel
- & Reinhold Schäfer
Oncogene 24 , 7542–7551

Rights & permissionsfor article Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival . Opens in a new window.
Research | 10 February 2020 | Open
SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells
Scientific Reports 10 , 1–16

Rights & permissionsfor article SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells . Opens in a new window.
Research | 29 July 2019 | Open
Serum PlGF and EGF are independent prognostic markers in non-metastatic colorectal cancer
Scientific Reports 9 , 1–12

Rights & permissionsfor article Serum PlGF and EGF are independent prognostic markers in non-metastatic colorectal cancer . Opens in a new window.
Research | 9 May 2019 | Open
SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer
- Ylenia Perone
- , Aaron J. Farrugia
- , Alba Rodríguez-Meira
- , Balázs Győrffy
- , Charlotte Ion
- , Andrea Uggetti
- , Antonios Chronopoulos
- , Pasquale Marrazzo
- , Monica Faronato
- , Sami Shousha
- , Claire Davies
- , Jennifer H. Steel
- , Naina Patel
- , Armando del Rio Hernandez
- , Charles Coombes
- , Giancarlo Pruneri
- , Adrian Lim
- , Fernando Calvo
- & Luca Magnani
Nature Communications 10 , 1–15

Rights & permissionsfor article SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer . Opens in a new window.
Research | 18 May 2018 | Open
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
- Anna Skucha
- , Jessica Ebner
- , Johannes Schmöllerl
- , Mareike Roth
- , Thomas Eder
- , Adrián César-Razquin
- , Alexey Stukalov
- , Sarah Vittori
- , Matthias Muhar
- , Bin Lu
- , Martin Aichinger
- , Julian Jude
- , André C. Müller
- , Balázs Győrffy
- , Christopher R. Vakoc
- , Peter Valent
- , Keiryn L. Bennett
- , Johannes Zuber
- , Giulio Superti-Furga
- & Florian Grebien
Nature Communications 9 , 1–16

Rights & permissionsfor article MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity . Opens in a new window.
Research | 23 July 2018
Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer
- Darren K. Patten
- , Giacomo Corleone
- , Balázs Győrffy
- , Ylenia Perone
- , Neil Slaven
- , Iros Barozzi
- , Edina Erdős
- , Alina Saiakhova
- , Kate Goddard
- , Andrea Vingiani
- , Sami Shousha
- , Lőrinc Sándor Pongor
- , Dimitri J. Hadjiminas
- , Gaia Schiavon
- , Peter Barry
- , Carlo Palmieri
- , Raul C. Coombes
- , Peter Scacheri
- , Giancarlo Pruneri
- & Luca Magnani
Nature Medicine 24 , 1469–1480

Rights & permissionsfor article Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer . Opens in a new window.
Research | 4 August 2017 | Open
Cell Dispersal Influences Tumor Heterogeneity and Introduces a Bias in NGS Data Interpretation
Scientific Reports 7 , 1–10

Rights & permissionsfor article Cell Dispersal Influences Tumor Heterogeneity and Introduces a Bias in NGS Data Interpretation . Opens in a new window.
Research | 16 November 2016 | Open
Colon cancer subtypes: concordance, effect on survival and selection of the most representative preclinical models
- Zsófia Sztupinszki
- & Balázs Győrffy
Scientific Reports 6 , 1–13

Rights & permissionsfor article Colon cancer subtypes: concordance, effect on survival and selection of the most representative preclinical models . Opens in a new window.
Research | 2 November 2016 | Open
AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients
- Giulia Bottai
- , Carlotta Raschioni
- , Borbála Székely
- , Luca Di Tommaso
- , Attila M Szász
- , Agnese Losurdo
- , Balázs Győrffy
- , Balázs Ács
- , Rosalba Torrisi
- , Niki Karachaliou
- , Tímea Tőkés
- , Michele Caruso
- , Janina Kulka
- , Massimo Roncalli
- , Armando Santoro
- , Alberto Mantovani
- , Rafael Rosell
- , Jorge S Reis-Filho
- & Libero Santarpia
npj Breast Cancer 2 , 1–10

Rights & permissionsfor article AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients . Opens in a new window.
Research | 10 January 2017 | Open
Benzyl Isothiocyanate potentiates p53 signaling and antitumor effects against breast cancer through activation of p53-LKB1 and p73-LKB1 axes
Scientific Reports 7 , 1–14

Rights & permissionsfor article Benzyl Isothiocyanate potentiates p53 signaling and antitumor effects against breast cancer through activation of p53-LKB1 and p73-LKB1 axes . Opens in a new window.
Research | 3 March 2015 | Open
Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis
- Beatrice Grabner
- , Daniel Schramek
- , Kristina M. Mueller
- , Herwig P. Moll
- , Jasmin Svinka
- , Thomas Hoffmann
- , Eva Bauer
- , Leander Blaas
- , Natascha Hruschka
- , Katalin Zboray
- , Patricia Stiedl
- , Harini Nivarthi
- , Edith Bogner
- , Wolfgang Gruber
- , Thomas Mohr
- , Ralf Harun Zwick
- , Lukas Kenner
- , Valeria Poli
- , Fritz Aberger
- , Dagmar Stoiber
- , Gerda Egger
- , Harald Esterbauer
- , Johannes Zuber
- , Richard Moriggl
- , Robert Eferl
- , Balázs Győrffy
- , Josef M. Penninger
- , Helmut Popper
- & Emilio Casanova
Nature Communications 6 , 1–14

Rights & permissionsfor article Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis . Opens in a new window.
Research | 27 November 2015 | Open
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
- Van T. M. Nguyen
- , Iros Barozzi
- , Monica Faronato
- , Ylenia Lombardo
- , Jennifer H. Steel
- , Naina Patel
- , Philippa Darbre
- , Leandro Castellano
- , Balázs Győrffy
- , Laura Woodley
- , Alba Meira
- , Darren K. Patten
- , Valentina Vircillo
- , Manikandan Periyasamy
- , Simak Ali
- , Gianmaria Frige
- , Saverio Minucci
- , R. Charles Coombes
- & Luca Magnani
Nature Communications 6 , 1–14

Rights & permissionsfor article Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion . Opens in a new window.

Refine your results by…

Filters

Filter By:

Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-κB

Currently favored sampling practices for tumor sequencing can produce optimal results in the clinical setting

BRD4 regulates key transcription factors that drive epithelial–mesenchymal transition in castration-resistant prostate cancer

Author Correction: Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets

Author Correction: SREBP1 drives keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer

Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion

Mapping Bromodomains in breast cancer and association with clinical outcome

Independent validation of induced overexpression efficiency across 242 experiments shows a success rate of 39%

Ribosomal protein S11 influences glioma response to TOP2 poisons

Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets

An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes

Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival

SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells

Serum PlGF and EGF are independent prognostic markers in non-metastatic colorectal cancer

SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer

MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity

Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer

Cell Dispersal Influences Tumor Heterogeneity and Introduces a Bias in NGS Data Interpretation

Colon cancer subtypes: concordance, effect on survival and selection of the most representative preclinical models

AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients

Benzyl Isothiocyanate potentiates p53 signaling and antitumor effects against breast cancer through activation of p53-LKB1 and p73-LKB1 axes

Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis

Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters